Ebola Outbreak Spreads in Central Africa, Prompting International Response
A fast-moving outbreak of the rare Bundibugyo ebolavirus has infected over 1,000 people and killed hundreds in the Democratic Republic of Congo (DRC) and Uganda. The World Health Organization (WHO) has declared it a public health emergency of international concern. There is currently no approved vaccine or treatment for this strain, and response efforts are complicated by attacks on healthcare facilities and regional conflict.
Facts First
- The Bundibugyo ebolavirus outbreak involves over 1,000 suspected cases and hundreds of suspected deaths across the DRC and Uganda.
- The World Health Organization (WHO) has declared a public health emergency and revised the national risk level in the DRC to 'very high'.
- There is no approved vaccine or treatment for the Bundibugyo strain of the virus, complicating containment efforts.
- Healthcare facilities have been attacked multiple times in the past week, hindering the medical response.
- International aid is being mobilized, with the UN releasing $60 million and the U.S. pledging $23 million and funding for up to 50 treatment clinics.
What Happened
Health authorities in the Democratic Republic of Congo (DRC) and Uganda are battling a significant outbreak of the Bundibugyo ebolavirus. As of late May, suspected cases in the DRC are approaching 1,000, with over 220 suspected deaths. Uganda has reported seven cases, including at least three infected health workers. The outbreak was first detected in early May in Ituri province, DRC, which borders Uganda. The virus spread undetected for weeks because initial tests were conducted for a more common type of Ebola. The World Health Organization (WHO) declared the outbreak a public health emergency of international concern on May 17. In recent days, healthcare facilities in the DRC have been attacked, including an incident where a Doctors Without Borders tent was set on fire, causing patients to flee.
Why this Matters to You
The outbreak involves a virus for which there is no approved vaccine or cure, which could make containment more difficult if it spreads further. The WHO assesses the risk of regional spread as high, though the global risk remains low. For now, the direct risk to people outside central Africa appears limited. However, the situation illustrates how disease outbreaks in one part of the world can require a coordinated global response, involving funding and expertise from multiple countries. The attacks on healthcare workers also highlight the challenges of delivering aid in conflict zones, which can allow diseases to gain a foothold.
What's Next
Containment efforts are now focused on active case finding, isolation, and contact tracing of approximately 1,400 contacts. The United Nations has released $60 million from its emergency fund, and the United States has pledged $23 million to support the response. An experimental vaccine developed by Oxford researchers is expected to be shipped to the region, though an expert stated it would take at least six to nine months before a vaccine or medicine becomes widely available. The response may continue to face challenges from community mistrust, as evidenced by the recent attacks, and from the ongoing conflict in eastern DRC, where parts are controlled by armed groups.